1 used dopamine agonists are bromocriptine and cabergoline.

2 ed study with the dopamine receptor agonists cabergoline (a D2 agonist) and pergolide (a D1/D2 agonis

3 generally treated with the dopamine agonists cabergoline and bromocriptine.

4                    New formulations (such as cabergoline and parenteral bromocriptine) with prolonged

5 uramine, the dopamine agonists pergolide and cabergoline, and more recently, the recreational drug ec

6 Medical therapy with somatostatin analogues, cabergoline, and pegvisomant is often also needed.

7                                              Cabergoline becoming the preferred drug in the treatment

8 rlapped in time and space in the placebo and cabergoline conditions, but not in the pergolide conditi

9  a previously reported extraction procedure, cabergoline could be determined in coyote plasma at conc

10 , fenfluramine, pergolide, methysergide, and cabergoline) have revealed that they and/or their metabo

11 low-picogram detection of an ergot alkaloid, cabergoline, in coyote plasma extracts.

12                                     Overall, cabergoline increased sensitivity of choice to informati

13 highly selective GHSR1a antagonist (JMV2959) cabergoline-induced anorexia was blocked.

14                                              Cabergoline is an N-acylurea derived from 9,10-dihydroly

15                                              Cabergoline is under investigation as an abortifacient i

16 e plasma at concentrations as low as 9 pg of cabergoline/mL of plasma.

17 d the effects of the selective D2/D3 agonist cabergoline on performance of a probabilistic risky choi

18                                              Cabergoline retained on the column was eluted as a discr

19                                              Cabergoline significantly influenced the way participant

20  manipulate these patterns with the D2 agent cabergoline, which induces a strong bias to amplify the

21 were treated with the selective DRD2 agonist cabergoline, which produced anorexia in wild-type and gh